Malaysia has conditionally approved the monoclonal antibody drug Evusheld for preventing Covid-19 in certain vulnerable populations.

“(It is indicated) to be used as pre-exposure prophylaxis to prevent Covid-19 for adults and adolescents aged 12 and above with a bodyweight of at least 40kg; and may not be able to produce an adequate immune response to Covid-19 vaccination or are contraindicated against Covid-19 vaccination,” Health Ministry director-general Dr Noor Hisham Abdullah said yesterday...